Should emicizumab be used in patients with acquired hemophilia A?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Should emicizumab be used in patients with acquired hemophilia A?

Published:2021-03 Issue:3 Volume:19 Page:637-644
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Tiede Andreas¹^ORCID,Kemkes-Matthes Bettina²,Knöbl Paul³

Affiliation:

1. Department of Hematology Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany

2. Interdisciplinary Hemostasis Unit Giessen University Hospital Giessen Germany

3. Department of Medicine 1 Division for Hematology and Hemostasis Medical University of Vienna Vienna Austria

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15208

Reference41 articles.

1. Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens

2. Bispecific Antibodies and Advances in Non–Gene Therapy Options in Hemophilia

3. Emicizumab Prophylaxis in Hemophilia A with Inhibitors

4. Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

5. Acquired hemophilia A: Updated review of evidence and treatment guidance

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitor eradication and treatment for acquired hemophilia A;Expert Review of Hematology;2024-05-09

2. Emicizumab as first-line therapy in acquired hemophilia A;Research and Practice in Thrombosis and Haemostasis;2024-05

3. Acquired Hemophilia: A Rare Complication of Pediatric Idiopathic Multicentric Castleman Disease;Pediatrics;2024-03-21

4. Emicizumab for acquired hemophilia A: Report of two cases and dosing strategies;eJHaem;2024-03-15

5. Innovative Therapies for Acquired Hemophilia A;Seminars in Thrombosis and Hemostasis;2024-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3